Christopher Ntoumenopoulos

Entropy Neurodynamics Limited | Executive Director

Mr Ntoumenopoulos has over 20 years of experience in financial markets in both capital raising and corporate strategy. He serves as the Managing Director of Twenty1 Corporate, an Australian based corporate advisory firm that provides funding and corporate support for innovative companies and technologies. He is currently a director of Tryp Therapeutics in Canada.

Companies and Roles

Company	Title	Tenure	Since
ENP Entropy Neurodynamics Limited	Executive Director	2yrs, 1mth	May 2024
MEB Medibio Limited	Non-Executive Director	3yrs, 3mth	Feb 2023
ILA Island Pharmaceuticals Limited	Non-Executive Director	1yrs, 8mth	Sep 2024
TRI TrivarX Ltd	Non-Executive Director	3yrs, 3mth	Feb 2023

Holdings

Company	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
ENP Entropy Neurodynamics Limited	14/04/26	16,250,000	19,191,176	49,046,580	N/A
TRI TrivarX Ltd	19/12/25	6,250,000	14,711,638	94,362,500	N/A
ILA Island Pharmaceuticals Limited	03/12/25	0	2,880,370	5,594,568	N/A
TYP	30/06/25	16,250,000	N/A	34,046,580	N/A
NSB	17/11/23	0	N/A	N/A	N/A

Transactions

Company	Date	Type	Amount	Price	Value	Notes
ENP Entropy Neurodynamics Limited	14/04/26	Issued	2,941,176	$0.034	$100,000	Placement
TRI TrivarX Ltd	19/12/25	Issued	75,000,000	$0.017	$1,275,000	As advised by the company
TRI TrivarX Ltd	19/12/25	Issued	6,250,000	$0.008	$50,000	Placement
TRI TrivarX Ltd	19/12/25	Issued	5,000,000	$0.008	$40,000	Placement
ENP Entropy Neurodynamics Limited	19/12/25	Issued	10,000,000	$0.034	$340,000	Issue of options

Any feedback about this profile? Contact Us

Build your watchlist

Already have account? Log in